Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone and Motivational Interviewing for Marijuana Dependence
NCT00149617Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cannabis use disorder (CUD) comparing Buspirone with Placebo (2 arms). Primary endpoint: Drug use at 16 weeks. Started Apr 2004; status: completed.
02
Drugs
buspirone
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00149617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149617.